
AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
AdvaMed’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
Heart attack symptoms in women can be different than in men and less well-known as heart attack-related. Women need their heart disease recognized and treated on equal footing with men.
AdvaMed and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
The Medtech Conference 2022 featured plenary speakers and panelists who shared enough wisdom to fill books. Read on for leadership lessons from the conference.
In a RealClearHealth op-ed, AdvaMed president and CEO Scott Whitaker outlines how the recently enacted medical device user fee agreement will help the FDA and medical technology innovators.
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
Congress overwhelmingly approved the fifth Medical Device User Fee Amendment (MDUFA) agreement, helping to ensure new medical technology receives a more efficient FDA review to reach patients sooner if approved.
Join over 400 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.